Search - tctmd.com

Displaying 241 - 260 of 3664

Sort: Relevancy | Date

News Conference News AHA 2024

Talking Sex: CVD Patients Want to Hear More From Clinicians

Caitlin E. Cox

November 20, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

Caitlin E. Cox

November 17, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

News Conference News AHA 2024

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

Michael O'Riordan

November 15, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Yael L. Maxwell

November 14, 2024

News Daily News

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

Caitlin E. Cox

November 12, 2024

News Conference News VIVA 2024

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

L.A. McKeown

November 11, 2024

News Daily News

Coronary CTA Reimbursement for US Hospitals to Double in 2025

Yael L. Maxwell

November 08, 2024

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Conference News TCT 2024

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

Caitlin E. Cox

October 31, 2024

Presentation TCT 2024

TCT 717: Prognostic Implications of Residual Global Quantitative Flow Ratio in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

Presenter: Francesco Giannini

October 30, 2024

Presentation TCT 2024

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Presenter: James Min

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

Presenter: Deepak Bhatt

October 29, 2024

Presentation TCT 2024

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Presenter: Ahmed Abdulelah

October 29, 2024

Advertisement

Talking Sex: CVD Patients Want to Hear More From Clinicians

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

US Obesity Epidemic Continues to Skyrocket, With No End in Sight

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

ChatGPT Again Shows Potential for Guiding Revascularization Decisions

Hypertensive Disorders of Pregnancy Lead to Earlier, More Severe CAD

DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years

Coronary CTA Reimbursement for US Hospitals to Double in 2025

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Bleeding After MCS in DanGer Shock: When, Where, and What to Do?

TCT 717: Prognostic Implications of Residual Global Quantitative Flow Ratio in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

TCT 102: First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease

The Transformation of Diagnosis and Risk Profiling for Ischemic Heart disease: An AI Case Study

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Role of Inflammation in Coronary Heart Disease: Why Does it Matter

TCT 250: Temporal Trends in Ischemic Heart Disease-related Mortality in Canada Over the Past 3 Decades

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content